Baudax Bio (BXRX) Corporate Presentation from NobleCon18Research, News and Market Data on Baudax BioNobleCon 18 Complete Rebroadcast
|
Take it to the next level. It doesn’t cost a penny.
Join the Channelchek Investor Community. Your name, email, zip, and investor type is all it takes to open the door to research reports, favorites tracking, and virtual and in-person roadshows / conferences. Even exclusive investment opps.
‌
Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌
5/3/2024
Energy
Emerging Growth Natural Resources, Energy, Industrials, and Transportation Company Featured at Noble Capital Markets’ September Virtual Equity Conference
Noble Capital Markets, a full-service SEC / FINRA registered broker-dealer, dedicated exclusively to serving emerging growth companies, is pleased to present the Natural Resources, Energy, Industrials, and Transportation Emerging Growth...
3 min read
‌
5/3/2024
Technology
Release – Conduent Announces Agreement to Sell its Casualty Claims Solutions Business to MedRisk
Conduent Incorporated (Nasdaq: CNDT), a global technology-led business solutions and services company, today announced an agreement to sell its Casualty Claims Solutions business to MedRisk, the nation’s largest managed care...
5 min read
‌
5/3/2024
Health
Release – PDS Biotechnology Announces Details of Virtual KOL Event
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious...
9 min read
‌
5/3/2024
Health
Release – Ocugen To Host Conference Call on Tuesday, May 14 At 8:30 a.m. ET To Discuss Business Updates And First Quarter 2024 Financial Results
Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that it will host...
3 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.